Skip to main content

The Globe and Mail

Three top stock picks from BMO Nesbitt Burns’ Stuart Hinshelwood

Stuart Hinshelwood is U.S. Equities Specialist at BMO Nesbitt Burns.

Top Picks:

Abbott Labs

Story continues below advertisement

  • Good valuation for EBITDA growth for a diversified health-care stock;
  • upside from Nutritionals, Pharma, Devices & Vascular following spin-off of Abbvie (ABBV) – mostly branded drugs. Upside to $42 (U.S.) ~20 per cent

Franklin Resources

  • High-quality asset manager (Templeton, Franklin & Bissett) for a decent valuation.
  • 55-per-cent equity and strong performance in Templeton Global Bond with lower duration and limited U.S. government exposure which is under-appreciated by the Street.

Time Warner

  • decent valuation, high FCF and good pure-play content and Time Inc. spin-off all catalysts

Past Picks: June 3, 2013

Allergan
Then: $98.94
Now: $90.99
Total return: -7.99 per cent

EMC Corp.
Then: $24.74
Now: $26.98
Total return: +9.53 per cent

Target
Then: $71.05
Now: $65.34
Total return: -7.46 per cent

Total return average: -1.97 per cent

Story continues below advertisement

Market outlook:

Neutral – with positive bias towards equity (same as June). Recent economic data was not great (i.e. no taper), yesterday`s shot of momentum usually precedes a price peak. U.S. markets are fairly-valued for economic progress. A balanced view overall.

Report an error
Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Please note that our commenting partner Civil Comments is closing down. As such we will be implementing a new commenting partner in the coming weeks. As of December 20th, 2017 we will be shutting down commenting on all article pages across our site while we do the maintenance and updates. We understand that commenting is important to our audience and hope to have a technical solution in place January 2018.

Discussion loading… ✨